Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus

Authors:

Abstract
No abstract available
Funding Information
  • University of North Carolina (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)
  • National Institutes of Health (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)
  • Merck (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)
  • Gilead Sciences (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)
  • Center for AIDS Research, University of North Carolina at Chapel Hill (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)
  • National Institutes of Health (P30 CA16068, R01-AI095690, R21-AI115207, T32-AI007151, R56-AI44667, P30 AI50410)

This publication has 32 references indexed in Scilit: